<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065571</url>
  </required_header>
  <id_info>
    <org_study_id>2009-0073</org_study_id>
    <nct_id>NCT01065571</nct_id>
  </id_info>
  <brief_title>Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity</brief_title>
  <official_title>Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Broad Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesis is that withdrawal of carrageenan will lead to a longer, relapse free
      interval in patients with ulcerative colitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the interval to relapse in patients with ulcerative colitis. The
      patients will be adults, who have been in remission for at least one month. They will have
      previously required corticosteroids to induce remission. Subjects will be instructed in a
      no-carrageenan diet and required to follow this diet for the duration of their participation
      in the clinical study. They will be randomized to receive either placebo capsules or capsules
      containing carrageenan 100 mg. In this way, the study will be a double blind study of
      no-carrageenan vs. carrageenan. Main study outcome is the interval to relapse. Since
      ulcerative colitis is associated with relapses, relapse is anticipated. Other outcome
      measures will include scores on questionnaires, including the SSCAI and the SIDBQ, and
      laboratory measurements of inflammation.

      Subjects will participate for one year or until relapse, with study visits every three months
      and telephone contacts every two weeks. After three months, participants will increase to two
      capsules daily, of either placebo or carrageenan.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to relapse</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>laboratory parameters of inflammation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>carrageenan-free diet with placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is the experimental arm in which subjects will be on a no-carrageenan diet and receive placebo capsules. This will test whether the no carrageenan diet leads to longer relapse-free interval for patients with ulcerative colitis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carrageenan-free diet w/ carrageenan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The carrageenan-free diet with carrageenan supplement will mimic the carrageenan normally consumed in the diet. The study will permit blinded comparison of carrageenan-free vs. carrageenan consumption.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carrageenan</intervention_name>
    <description>The intervention is the carrageenan-free diet. Supplementary carrageenan capsules will be given to mimic the carrageenan in the normal diet.</description>
    <arm_group_label>carrageenan-free diet w/ carrageenan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>dietary intervention with no-carrageenan diet</intervention_name>
    <description>The intervention will consist of the no-carrageenan diet.</description>
    <arm_group_label>carrageenan-free diet with placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ulcerative colitis

          -  Adult

          -  In remission

          -  Required corticosteroids to induce remission

          -  Able to make food choices and follow diet

        Exclusion Criteria:

          -  Not able to make food choices
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joanne K Tobacman, M.D.</last_name>
    <phone>312-569-7826</phone>
    <email>jkt@uic.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne K. Tobacman, M.D.</last_name>
      <phone>312-569-7826</phone>
      <email>jkt@uic.edu</email>
    </contact>
    <investigator>
      <last_name>Joanne K. Tobacman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen B. Hanauer, M.D.</last_name>
      <phone>773-702-1466</phone>
      <email>shanauer@bsd.uchicago.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2010</study_first_submitted>
  <study_first_submitted_qc>February 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2010</study_first_posted>
  <last_update_submitted>August 6, 2013</last_update_submitted>
  <last_update_submitted_qc>August 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Joanne Kramer Tobacman</investigator_full_name>
    <investigator_title>Associate Professor of Clinical Medicine</investigator_title>
  </responsible_party>
  <keyword>relapse</keyword>
  <keyword>carrageenan</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 30, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

